Production of lytic phages

Patent metadata

Field	Value
Publication number	US-11739304-B2
Application number	US-202217742693-A
Country	US
Kind code	B2
Filing date	May 12, 2022
Priority date	May 12, 2021
Publication date	Aug 29, 2023
Grant date	Aug 29, 2023

Abstract

The present invention concerns a production bacterial cell for producing lytic phage particles or lytic phage-derived delivery vehicles, said production bacterial cell stably comprising at least one phage structural genes and at least one phage DNA packaging genes, said phage structural gene(s) and phage DNA packaging gene(s) being derived from a lytic bacteriophage,
wherein the expression of at least one of said phage structural genes and/or at least one of said phage DNA packaging gene(s) in said production bacterial cell is controlled by an induction mechanism.

First claim

The invention claimed is:

1. Production bacterial cell for producing lytic phage particles or lytic phage-derived delivery vehicles, said production bacterial cell stably comprising the phage structural genes and phage DNA packaging genes of a lytic bacteriophage,
wherein the expression of said phage structural genes and said phage DNA packaging genes in said production bacterial cell is controlled by an induction mechanism comprising phage excision/insertion genes, phage DNA replication genes, and phage regulation genes of a second, non-lytic bacteriophage, wherein said phage excision/insertion genes, phage DNA replication genes and phage regulation genes are neither phage DNA packaging genes nor phage structural genes,
wherein said production bacterial cell does not comprise phage excision/insertion genes and/or phage replication genes of the lytic bacteriophage,
wherein said production bacterial cell is a P. freudenreichii bacterial cell,
wherein the lytic bacteriophage is a C. acnes phage and
wherein the second, non-lytic bacteriophage is a P. freudenreichii phage.

2. The production bacterial cell according to claim 1 , wherein said bacterial cell further comprises a payload to be packaged into said phage particles or phage-derived delivery vehicles.

3. The production bacterial cell according to claim 2 , wherein said payload is a nucleic acid payload comprising a packaging site derived from said lytic bacteriophage.

4. The production bacterial cell according to claim 2 , wherein said payload is to be delivered into targeted bacterial cells.

5. The production bacterial cell according to claim 4 , wherein said payload is stably maintained in said targeted bacterial cells.

6. The production bacterial cell according to claim 4 , wherein said payload does not replicate in said targeted bacterial cells.

7. The production bacterial cell according to claim 4 , wherein said payload comprises a sequence of interest.

8. The production bacterial cell according to claim 7 , wherein said sequence of interest only generates an effect in said targeted bacterial cells.

9. The production bacterial cell according to claim 8 , wherein said targeted bacterial cells are from a species or strain different from the production bacterial cell.

10. The production bacterial cell according to claim 1 , wherein said induction mechanism further controls the copy number of said phage structural genes and said phage DNA packaging genes.

11. The production bacterial cell according to claim 2 , wherein said induction mechanism further controls the copy number of said payload in said production bacterial cell.

12. The production bacterial cell according to claim 2 , wherein another induction mechanism controls the copy number of said payload in said production bacterial cell.

13. The production bacterial cell of claim 1 , wherein said phage structural genes and phage DNA packaging genes of said lytic bacteriophage are comprised in at least one plasmid, chromosome and/or helper phage.

14. The production bacterial cell according to claim 1 , wherein said production bacterial cell is from the same bacterial strain as the bacterial strain from which said non-lytic bacteriophage comes and/or that said non-lytic bacteriophage targets.

15. The production bacterial cell according to claim 1 , comprising the entire structural operon of the lytic bacteriophage.

Assignees

• Eligo Bioscience

Inventors

• Fernandez Rodriguez Jesus
• Decrulle Antoine
• Leveau Aymeric
• Canadas Blasco Ines
• Mathieu Aurélie
• Carlier Thibault

Classifications

• C12N7/00 Primary

  Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title

• C12N15/70 Primary

  Vectors or expression systems specially adapted for E. coli · CPC title

• C12N2800/101

  for bacteria · CPC title

• C12N2795/10352

  relating to complementing cells and packaging systems for producing virus or viral particles · CPC title

• C12N2795/10252

  relating to complementing cells and packaging systems for producing virus or viral particles · CPC title